Peripheral gila help ensure that motor and sensory axons are bathed in the appropriate ionic and biochemical environment. In Drosophila, peripheral gila help shield these axons against the high K ÷ concentration of the hemolymph, which would largely abolish their excitability. Here, we describe the molecular genetic analysis of gliotactin, a novel transmembrane protein that is transiently expressed on peripheral gila and that is required for the formation of the peripheral bloodnerve barrier. In gliotactin mutant embryos, the peripheral gila develop normally in many respects, except that ultrastructurally and physiologically they do not form a complete blood-nerve barrier. As a result, peripheral motor axons are exposed to the high K + hemolymph, action potentials fail to propagate, and the embryos are nearly paralyzed.
Introduction
Gila play a diverse set of roles during the development and functioning of the nervous system. During development, they provide cues to help guide migrating cells and growth cones, and they secrete a variety of cytokines and growth factors that help control the patterning of neuronal differentiation. Throughout life, they wrap and insulate axons and help establish and maintain the blood-brain barrier in the central nervous system (CNS) and the bloodnerve barrier in the periphery.
In vertebrates, much is known about the reciprocal interactions between Schwann cells and the peripheral motor and sensory axons. For example, contact with axons stimulates Schwann cell proliferation and triggers Schwann cells either to ensheath and myelinate single large axons or to ensheath multiple small (unmyelinated) axons. In triggering myelin formation, axonal contact also results in the induction of many myelin-specific genes (reviewed by Doyle and Colman, 1993; Lemke, 1993) . A number of myelin-specific proteins that are important for the structure of myelin have been isolated. Abnormal nervous system "i'Present address: Department of Zoology, University of British Columbia, Vancouver, British Columbia V6T1Z4, Canada.
function results from mutations in several of these myelin genes, including shiverer and myelin deficient, which are disruptions in myelin basic protein (MBP), jimpyand rumpshaker, disruptions in PLP, and trembler, a disruption in PMP22 (reviewed by Lemke, 1993) . Toxin ablation of myelinating Schwann cells also results in demyelination and peripheral neuropathy (Messing et al., 1992) . Therefore, disruption of the glial sheath around peripheral axons results in loss of nerve function.
The precise molecular mechanisms controlling the sequential interactions between gila and axons are not yet completely understood. Genetic analysis in an organism such as Drosophila offers one way to discover novel molecules that are essential for glial development and function, and that, owing to their low abundance or transient expression, might have gone undetected in other systems. While Drosophila gila do not form myelin, they develop and function in a manner analogous to that of gila in higher organisms. The peripheral gila in Drosophila are similar to vertebrate nonmyelinating Schwann cells in their morphology, development, and composition. In Drosophila, peripheral gila help wrap and insulate peripheral motor and sensory axons. One of their roles is to protect these axons from the insect hemolymph, which contains a high K ÷ concentration that would largely abolish their resting and action potentials (Treherne and Pichon, 1972; Lane et al., 1975) . Lossof-function mutations in any gene that is essential for the establishment and maintenance of this peripheral bloodnerve barrier should lead to paralysis.
In this paper, we describe the cloning, characterization, and genetic analysis of gliotactin, a novel transmembrane protein in Drosophila that is transiently expressed on embryonic peripheral gila and that plays an essential role in the establishment of the blood-nerve barrier. In gliotactin mutant embryos, the peripheral gila develop normally in terms of their birth, migration, and differentiation, with one exception: ultrastructurally and physiologically, they do not form a complete blood-nerve barrier. The peripheral axons within these nerves are exposed to the high K + hP_~o-lymph, and as a result, action potentials fail to propagate.
Results

Identification and Cloning of the gliofactin Gene
This study began with a set of enhancer trap lines in Drosophila Nose et al,, 1992) that have identical staining patterns that primarily label many gila associated with the peripheral nervous system (PNS), This set includes lines rL82, J29, AE2, and AM72, all of which are homozygously viable and are located at position 35E1-2, These enhancer trap lines label gila along the two major peripheral motor nerves, which are the intersegmental nerve (ISN) and the segmental nerve (SN), one of the exit gila, and a number of gila at the midline of the CNS, Genomic DNA flanking the P elements in lines AE2, J29, and rL82 was isolated by using the plasmid rescue technique and was used to isolate a series of overlapping genomic and cDNA clones. The largest cDNA clones were sequenced and found to contain an open reading frame (ORF) of 2868 bp. One clone (AE2-7.41) was used to probe a Northern blot of embryonic poly(A) ÷ RNA and hybridized to a single -6 kb band.
Digoxigenin-labeled anti-sense RNA probes were generated frQm the cDNA clone AE2-7.41 and were used for whole-mount in situ hybridization of staged embryos. The mRNA expression pattern ( Figure 1 ) coincides with the pattern of 13-galactosidase expression in the original enhancer trap line. RNA is detected in most peripheral glia, some exit glia, and in a number of glia at the midline of the CNS. Prior to glial expression, there is some epidermal staining in broad, diffuse stripes at early stage 12 that diminishes. This epidermal staining is not detected in the enhancer trap lines.
The genomic structure of the gliotactin gene is outlined in Figure 2A . The transcription unit is divided into at least three exons. The size of the gliotactin mRNA detected by Northern blot analysis is 2 kb longer than the largest cDNA clone. Because no polyadenylation sequence is found in any of these cDNA clones, the gliotactin gene must extend farther downstream and may include other exons. The putative start of translation is located in the second small exon (Figure 2A ). The precise genomic locations of the three P elements was determined by sequencing the ends of the plasmid rescue and polymerase chain reaction (PCR) clones ( Figure 2B ). Given the length of the mRNA in Northern blot analysis, it is possible that the 5' untranslated region of the gene extends farther upstream.
The gliotactin Gene Encodes a Novel Transmembrane Protein
The gliotactin deduced protein sequence is shown in Figu focused on the midline glia, while .fD] is a more external focal plane). The arrow in (C) marks an exit gila expressing RNA; the arrowhead in (C) marks the midline glia expressing RNA. With the exception of these midline gila, most CNS glia do not express gliotactin. The position of the intersegmental nerve (ISN) and the segmental nerve branches a and c (SNa and SNc) are indicated. The digoxigenin-labeled RNA probes were detected by using alkaline phosphatase and reacted with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate toluidinium (BCIP) (purple reaction product). Embryos were double stained with the MAb 1D4 (anti-fasciclin II) using horseradish peroxidase (HRP) immunocytochemistry (brown reaction product). Scale bar, 10 ~m. staining of the peripheral glia is first detected at stage 13 and becomes steadily stronger throughout later stages. At stages 16-17, the entire surface of these glia appears to stain. The gliotactin-expressing glia extend from the nerve roots just inside the CNS along most of the major peripheral nerves, including the ISN up to the main tracheal trunk and along two SN branches, the SNa and SNc ( Figure 4C ). When compared with the anti-RK2 antibody, which stains all known peripheral glia (Campbell et al., 1994) , the gliotactin protein is expressed on all of the glia associated with the peripheral motor and sensory nerves; it is not expressed, however, on the glia associated with sensory structures.
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A pair of glial cells at the midline of the CNS also stain strongly at stages 16-17; these cells are also positive in the whole-mount RNA in situs. At earlier stages (stages 12-13), there is some faint staining along the midline that is not seen in the in situs. Since this staining is absent in mutant embryos, it is likely to represent some small amount of authentic gliotactin expression at the midline.
At early stage 12, there is some diffuse epidermal staining that diminishes and is completely absent by stages 16-17. There is also staining restricted to the trachea at stages 13-14 that becomes concentrated to small patches on the main tracheal trunks (Figure 4) . At later stages, there is staining associated with the hindgut.
In third instar larvae, gliotactin expression is extremely weak, even with the most sensitive detection protocols. A pair of stained cells are observed at the midline of the thoracic ganglia and along the large nerve trunks leaving the CNS. There are also faint patches of staining in the larval leg and antennal discs, in the trachea, and in the PNS. However, the glia enwrapping the peripheral nerves, the major location of gliotactin expression in the embryo, show little or no protein expression in the larvae.
Generation and Characterization of Mutations in the gliotactin Gene
To generate mutations in the gliotactin gene, imprecise excisions of the P elements in enhancer trap lines J29 (blue-black) that reveals the location of the nuclei of the peripheral glia and all CNS glia (feathered arrow) except the m idline giia, which do not stain. The staining of the glial nuclei is intensified with nickel. The embryo is double stained with MAb 1D4 (anti-fasciclin II) (brownstained axons). The arrow in (D) marks the extension of the ISN past the main tracheal (T) trunk and into the dorsal muscles, and the feathered arrow marks a glial nucleus at a side branch of the ISN that does not express gliotactin. The arrows in (E) mark the bifurcation of the SNa in the lateral muscle region. These locations of motor axons should be compared with the extent of the glial wrapping of the peripheral nerves as shown by the arrows marking the end of the gliotactin staining in (A) and (B).
Scale bar, 10 p.m. molecularly by using PCR. Gliotactin-specific oligonucleotides were used to amplify DNA isolated from heterozygous mutant adults and homozygous mutant embryos. The resulting PCR products were sequenced and analyzed. All of the lethal excisions have at least the first exon and a part of the first intron deleted (see Figure 2A ). Similar PCR analysis shows that the viable excision AE2A4a is a precise excision.
These lethal excisions appear to be both mRNA and protein null mutations, as indicated by in situ hybridization and immunocytochemical analysis. The mutant lines were crossed to balancers containing lacZ embryonic markers, and homozygous mutant embryos were identified as negative for l~-galactosidase expression. Whole-mount in situs were carried out on three of the lethal lines, 1(2)AE2A45, 1(2)AE2/14b, and 1(2)AE2/16a, and on the precise excision AE2z14a. All three mutant lines show no detectable RNA expression, whereas the viable line is indistinguishable from wild type. These same mutant lines show no antibody staining, whereas the precise excision line AE2/i4a has the same staining pattern and signal intensity as does wild type. In addition, the three EMS alleles (1(2)35Dg RAR77, 1(2)35Dg P29, and 1(2)35Dg ~) also fail to stain with the antigliotactin antibody.
The mutant embryos appear normal in all embryonic tissues as assayed by antibody staining (see Experimental Procedures). The PNS and CNS appear normal. The number and morphology of muscles are normal, and the rectoneurons appear to innervate these muscles in the appropriate locations. The trachea of these embryos appear normal, except that they do not fill with air toward the end of embryogenesis. The peripheral glia have the normal number and location, as indicated by staining mutant embryos with the RK2 antibody (Figure 4) , which labels the nuclei of all peripheral glia (Campbell et al., 1994) .
The lethal mutations were analyzed to determine the time of lethality. Mutant embryos progress normally to very late stages and then fail to hatch. The trachea failing to fill with air is unlikely to be the cause of late embryonic lethality, since embryos can survive for several days in the absence of an air-filled tracheal system (Manning and Krasnow, 1993) . Rather, the mutants appear morphologically normal, but the embryos fail to show the characteristic coordinated peristaltic movements associated with the latest stages of embryogenesis. There is some motion detected in the mutants, but this movement tends to be uncoordinated and rarely extends down the length of the embryo. A sharp tap with a blunt needle to the head or tail fails to elicit any response in the majority of embryos (>90%) in mutant lines 1(2)AE2/14b and 1(2)AE2/145 (n --84 and n --69, respectively), whereas the viable excision embryos always move (>99%; n = 143). Thus, the mutants are partially paralyzed.
Electrophysiological Analysis of gliotactin Mutants
The normal pattern of movement, missing from the mutant embryos, is restored in dissected mutant embryos by replacing the hemolymph with a low K + saline solution. To determine the physiological basis for this behavioral defect, electrophysiological experiments were performed on dissected late stage (20-22 hr after egg laying at 25°C) mutant (AE2/14b) and control (AE2/14a) embryos. The viable line is not distinguishable from wild type.
To monitor changes in the spontaneous activity ( Figure  5 ), muscle 6 was voltage-clamped at -60 mV and endogenous synaptic currents recorded over a range of different external K ÷ concentrations. At a low K ÷ concentration (2 mM) in the bathing solution, the mutant embryos display normal coordinated activity in muscle 6, similar to that seen in control embryos. The muscle physiology, the size of synaptic currents, and the patterning of bursts of synaptic activity all appear normal. Each burst underlies a single muscle contraction during the normal peristaltic body movements occurring during late embryonic movement and larval locomotion.
Changes in the Na ÷, Ca ÷2, or Mg +2 concentrations have no differential effect on mutant compared with control embryos. On the other hand, changes in the K ÷ concentration have dramatic effects on mutant embryos compared with controls ( Figure 5) . A 10-fold increase in K ÷ concentration (20 mM) causes a significant depression in synaptic activity in muscle 6 of the mutant embryos; both the duration and frequency of motor bursts are greatly reduced. These embryos show reduced motor activity, and both the frequency and coordination of muscle peristalsis are dramatically impaired. This depression is even more pronounced at K ÷ concentrations of 40 raM, which is approximately the concentration of K ÷ found in Drosophila hemolymph (Ashburner, 1989) . Patterned synaptic communication is nearly abolished. Synaptic currents are still observed, but they no longer occur in patterned, high frequency bursts. Coordinated movement is absent.
To determine whether action potential propagation is failing (Figure 6 ), we stimulated the ISN near the point where it exits the CNS and recorded synaptic currents. We used the more distal muscle 4 to eliminate passive stimulation of the nerve terminal, which is occasionally observed in muscle 6. In wild-type embryos, muscle 4 receives at least three synaptic inputs that can be clearly distinguished in current recordings ( Figure 6A ). In the control embryos, robust transmission in all three axons is maintained at both low K ÷ concentrations (2 mM) and high, physiological K ÷ concentrations (40 mM). The amplitude of these synaptic currents is slightly reduced at high K ÷ concentrations, presumably owing to a reduced resting potential in the presynaptic terminal, which lacks a protective glial covering in the embryo (see below). In gliotactin mutant embryos, robust transmission along all three axons is maintained at low K ÷ concentrations but is eliminated at high K ÷ concentrations. In addition, an increase lag between synaptic currents is usually seen in the mutants even at low K ÷ levels, suggesting that the rate of conduction of the action potential is affected in the mutant even in low K ÷ concentrations.
Electron Microscopic
Analysis of gliotactin Mutants
Serial section electron micrographs of peripheral nerves in mutant embryos (n = 8) and wild type (n = 6, Canton S; n = 1, precise excision) at mid-stage 17 were examined to look for potential defects in glial ultrastructure or glial wrappings around peripheral axons. At this stage, the neuromuscular system is fully functional, including coordinated synaptic bursts and peristaltic movements (Broadie and Bate, 1993) .
In all of the mid-stage 17 wild-type embryos examined, the glial wrappings around the peripheral motor axons do not extend to the synaptic terminals, but rather terminate about 5-10 I~m before the synapses, thus leaving 5-10 I~m of naked motor axon exposed to the high K ÷ hemolymph. At this stage, glial wrappings extend out the JSN to the main tracheal trunk; out the SNa to before its bifurcation (just past muscle 12); out the SNb for only a short distance after it enters the ventral muscle region; and out the SNc. These results mirror the extent and staining pattern of the peripheral glia observed with the anti-gliotactin MAb (see Figure 5 ). Once the motor axons begin to split away from the major motor nerves and extend toward their specific muscle targets, they are no longer covered by glial wrappings in mid-stage 17 embryos. For instance, at mid-stage 17, the motor axons that extend the farthest in the control (viable excision line AE2z14a), robust transmission is maintained at both low K ÷ (2 mM) and high, physiological K ÷ (40 mM)
concentrations. In the gliotactin mutant (I(2)AE2A4b), robust transmission is maintained at low K ÷ but eliminated at high K + concentrations. An increased lag between synaptic currents is usually seen in the mutants even at low K ÷ concentrations.
(B) The distribution in transmission efficiency in the control and mutant at both low and high K ÷ concentrations. A given nerve stimulus generates action potential conduction in either all axons innervating muscle 4 (three axons) or a subset of axons (one to two), or it fails to elicit action potentials in any of the axons (zero). In the control, the normal response is that all three axons conduct action potentials at both low and high K ÷ concentrations, and complete transmission failure is a rare event (<10%). In the mutant, successful transmission occurs in most axons at low K ÷ levels, but transmission usually fails in all axons (>75%) at high K ÷ levels. Each bar represents the mean _+ SD for at least ten embryos of each genotype.
(aCC, the three Us, and RP2 axons in the ISN) are wrapped by peripheral gila for about 110-120 I~m of their length and then are naked for the last/>10 I~m. This is in contrast with third instar larvae, in which the gUa do extend out to the synaptic terminals and fully enwrap the motor axons (Atwood et al., 1993) . We have also observed antigliotactin antibody staining of nerve terminals on larval muscles, further confirming the presence of glial processes at larval nerve terminals. nerves and have a relatively normal morphology. Particularly in regions of the glial cell bodies, the glial processes appear to wrap around the axons in a normal fashion (compare Figure 7A with Figure 7B ). However, two differences are apparent. First, in wild-type embryos at mid-stage 17, the wrappings are complete in the regions of the peripheral nerves between the glial cell bodies ( Figure 7C ), whereas in gliotactin mutant embryos at the same stage, the glial wrappings are incomplete and have openings and large gaps ( Figure 7D ). Second, toward the ends of the nerves, the glial wrappings terminate or become incomplete sooner than in wild-type embryos, leaving longer stretches of naked motor axons (data not shown). This is most apparent for the SNb, where in wild-type embryos the glial processes extend and completely enwrap the motor axons for 5 t~m or so along the SNb into the ventral muscle region, whereas in gliotactin mutant embryos, the SNb axons are naked or incompletely wrapped for most of their length. These results suggest that in wild type, the glial wrappings are complete and thus are likely to protect the peripheral axons from the high K ÷ concentration in the hemolymph. In the gliotactin mutants, on the other hand, the wrappings are not complete, leaving gaps and openings that allow direct exposure of the axons to the bathing solution. To confirm this conclusion independently, we treated dissected mutant (n = 3) and wild-type (n = 2) mid-stage 17 embryos to fixatives containing 1.5-3.0 mg/ml ruthenium red (see Experimental Procedures) (Figure 8 ). Ruthenium red is a highly charged, electron-dense cation of low molecular weight and size (786 Da; diameter 1.13 nm) that binds to polyanionic macromolecules such as heparin and condroitin sulfate in basement membranes, in extracellular matrix, and on cell surfaces (Luft, 1971a (Luft, , 1971b . Ruthenium red does not cross cell membranes and when applied exogenously without detergent is an excellent extracellular tracer for electron microscopy (EM).
In wild-type embryos, ruthenium red is seen around the outside and between some of the glial wrappings, but none completely penetrates the glial junctions around the axons and none is found around the axons themselves ( Figures   8A and 8C ). In contrast, in gliotactin mutant embryos treated in the same way, ruthenium red enters the peripheral nerves and is seen decorating the membranes of the axons (Figures 8B and 8D) . ISN (A and B) , and along the SNa just prior to its bifurcation past muscle 12 (C and D). In contrast with the conventional EM shown in Figure 7 , these embryos were stained with ruthenium red, an electron-dense extracellular tracer (see text for details). The sections shown here are representative of the similarities (A compared with B) and differences (C versus D) observed in mutant (n = 3, /(2)AE2/14b allele) versus wild-type (n = 2, Canton S) embryos. G, glial cell; T, tracheal cell; arrowheads, ruthenium red staining of basement membranes around cells. (A) In wild type, ruthenium red stains the outside of the nerve and the area between some glial processes (arrow), but does not penetrate the inner glial junctions and thus does not stain the membranes of the axons in the ISN.
(B) At a similar location in the gliotactin mutant, ruthenium red fully penetrates the nerve and stains the membranes of the axons in the ISN (arrow). (C) The SNa in wild type is similar to the ISN in that ruthenium red stains the surfaces of the gila (arrow) but does not penetrate the inner glial junctions and thus does not stain the membranes of the axons.
(D) In contrast, in the gliotactin mutant, the axons in the SNa are stained by ruthenium red (arrow).
Scale bar, 0.5 p.m.
Discussion
In this paper, we describe the cloning, characterization, and genetic analysis of gliotactin, a novel transmembrane protein that plays an essential role in the establishment of the peripheral blood-nerve barrier in Drosophila. Gliotactin is transiently expressed on the surface of the peripheral glia that wrap the peripheral motor and sensory axons in the embryo and on at least some midline glia in the CNS. The gliotactin protein has a putative signal sequence, a transmembrane domain, and a cytoplasmic domain with no obvious similarity to other known proteins. The gliotactin protein also contains an extracellular domain with sequence similarity to members of the serine esterase family. The serine esterase domain is likely to be a structural motif only, as the serine residue essential for enzymatic activity is missing in the gliotactin protein and in two other Drosophila serine esterase-like proteins, neurotactin and glutactin. Glutactin is a secreted protein found in basement membranes (Olson et al., 1990) . Neurotactin is a transmembrane protein expressed in the nervous system ; neurotactin is found at sites of cellcell contact and can mediate heterophilic cell aggregation (Barthalay et al., 1990) . Thus, gliotactin belongs to a family that includes members that appear to mediate cell-cell and cell-matrix interactions during development. One of the functions of the gliotactin-expressing peripheral glia in Drosophila is to help ensure that motor and sensory axons are protected for most of their length from the high K ÷ hemolymph that would otherwise abolish their excitability and lead to paralysis. In wild-type embryos, the gliotactin-expressing peripheral glia do their job. At the ultrastructural level, these glia completely enwrap the peripheral axons for much of their length. Moreover, ruthenium red, a small electron-dense extracellular tracer, does not penetrate the peripheral nerves to stain the axons in wild-type embryos.
In gliotactin mutant embryos, however, the peripheral glia fail at this crucial job. At the light microscope level, the peripheral glia in the mutant embryos appear normal in their number, location, and morphology. However, these glia do not form a complete peripheral blood-nerve barrier, resulting in major physiological and behavioral deficits. The gliotactin mutant embryos are partially paralyzed, show no coordinated peristaltic movements, and fail to hatch. When bathed in a high K + solution (40 mM), gliotactin mutants physiologically show very little motor activity, and action potentials fail to propagate in the peripheral motor nerves. These deficits can be rescued by bathing the dissected embryos in a low K ÷ solution (2 mM). These results confirm that the sensory and motor systems are properly wired and can function normally in the mutant embryos. Immunohistochemistry with various antibodies indicates that the structure of the PNS is normal. Ultrastructurally, the peripheral nerves in the mutant embryos show gaps and openings in their glial wrappings; moreover, the gila allow small molecules such as ruthenium red to penetrate the nerves freely and bathe the axons.
Thus, the absence of gliotactin protein leads to a failure to form a peripheral blood-nerve barrier. As a result, the peripheral motor and sensory axons are exposed to a high K ÷ extracellular environment, and this in turn leads to the behavioral and physiological defects observed in the mutants. Such a conclusion is consistent with previous results from a variety of organisms, showing that exposure of axons to high K ÷ leads to blockage of excitability and to paralysis (Grossman et al., 1979; Kocsis et al., 1983) .
One surprise arising from our electron microscopic examination of wild-type embryos is that in mid-stage 17 embryos, the glial wrappings around the peripheral motor axons do not extend all of the way out to the synaptic terminals, but rather terminate about 5-10 pm before the synapses, thus leaving 5-10 p,m of naked motor axon exposed to the high K ÷ hemolymph. This is in contrast with third instar larvae, in which the gila do extend out to the synaptic terminals and fully enwrap the motor axons (Atwood et al., 1993) . While it is difficult to determine the exact consequence of 5-10 p,m of naked motor axon on the magnitude of the action potential, it seems likely that the action potential is passively conducted for this final short stretch. In the absence of measurements of the membrane capacitance and core and membrane resistance of these embryonic axons, it is impossible to calculate the appropriate space constants of these axons accurately. Using numbers for resistances obtained from mammals and squid, we determined that the space constant for these axons (0.1-0.2 I~m diameter) ranges from 60 to 180 pm. Such estimates are in agreement with what we infer from the wild-type versus the mutant physiology. Evidently, the wild-type embryonic axons can maintain their excitability when exposed to high K ÷ hemolymph for their final 5-10 p.m of length. In contrast, in the g/iotactin mutant, exposure of these axons to the high K ÷ hemolymph for large portions of their 50-120 t~m length leads to either an intermittent or complete block in the propagation of action potentials. This is presumably due to the decrement in the passively conducted potentials along the stretches exposed to high K ÷. In larvae, peripheral nerves are often many millimeters in length, and thus the glial wrappings need to extend for the entire length of the peripheral nerves.
How does gliotactin control the establishment of the peripheral blood-nerve barrier in Drosophila? The protein probably does not function as a major glial adhesion molecule. The protein does not mediate aggregation of transfected $2 cells. The protein is only transiently expressed while the glia are forming the peripheral bloodnerve barrier, but once this process is complete, the protein largely disappears and is barely detectable in larvae. In regions of glial cell bodies, the glial wrappings appear normal even in the absence of gliotactin expression. Rather, it is in the region where neighboring glial processes should form a complete glial sheath around the axons that we detect openings and gaps in the gliotactin mutant. Therefore, we suggest that gliotactin functions in some sort of cell-cell interaction mechanism to ensure that neighboring gila completely enwrap the peripheral axons. It seems plausible that such a necessary interaction could either be glial-glial or glial-axonal. Thus, the present model leads to the prediction that either peripheral glia or peripheral axons express a ligand that binds to gliotactin and induces the processes from neighboring glial cells to enwrap the peripheral axons completely. It is likely that the molecular machinery controlling these events has counterparts serving similar functions in other organisms, and thus, that gliotactin-like molecules may be required for the formation of the blood-nerve barrier in mammals as well.
Experimental Procedures
DNA Techniques
Standard molecular biology methods were used (Maniatis et al., 1982) . Genomic DNAs flanking the enhancer trap P elements were isolated by using the plasmid rescue technique. The largest plasmid rescue clone, a region of 4 kb flanking the AE2 P element (AE2Sstl), was used to screen the Kolodkin ~.DASH genomic library and the Zinn Zgtl 1 cDNA library (Zinn et al., 1988) . The clones obtained all mapped to position 35E1-2 and cross-reacted with the plasmid rescue clones obtained from the other P element lines. Four independent cDNA clones (ranging from 3 to 4 kb) were sequenced by the dideoxy method.
In Situ Hybridization
Digoxigenin-labeled antisense or sense RNA probes were made from the largest cDNA clone, AE2-7.41. These probes were generated for whole-mount in situ hybridization of fixed embryos as described previously (Kopczynski and Muskavitch, 1892) , with minor modifications (C. Kopczynski). The treated embryos were antibody stained as described below.
Generation of Antibodies
Bacterial trpE fusion genes were constructed in the pATH vectors (Koerner et al., 1991) by using a number of fragments from the giiotactin cDNA AE2-7.41. The only fusion to produce a significant immune response contained the last 70 amino acids of the protein coding sequence (Pstl[2841]-Clal fragment). After induction, fusion protein was extracted from purified inclusion bodies. Mice were injected with approximately 50-100 p.g of protein emulsified in adjuvant. After a number of rounds of injections, a positive response was detected, and spleen lymphocytes from one mouse were fused to myeloma cells to generate MAb-producing clones. Clones were tested by both enzymelinked immunosorbent assay and immunostaining of fixed embryos. One clone was isolated (1F6) and subcloned that showed a strong response similar to that of the polyclonal antisera.
Cell Culture Experiments
$2 cells (Schneider, 1972) were grown and selected as described previously (Grenningloh et al., 1990) . $2 cells were transformed by use of the lipofectin reagent (Bethesda Research Laboratories), with the following plasmids: pMHA3, containing the AE2-7.41 cDNA under the control of the methallothionein promoter (Bunch et al., 1988) , and pPC4 to confer ~-amanitin resistance as the selectabte marker. Cells from 10 ml cultures were pelleted, rinsed in serum-free Schneider's media, and then induced in the presence of 0.7 mM CuSO4 in serumfree media for 24 hr at room temperature.
Generation and Analysis of Mutations
The enhancer trap P elements (P[w*,/acZ]) of lines AE2 and J29 were mobilized by crossing to flies carrying a stable source of transposase, the P[ry +, 42-3] chromosome (Robertson et al., 1988) . For each enhancer trap, a set of lethal excisions was isolated that failed to complement the lethals from the other P element excisions, failed to complement the deficiencies Df(2L) osp29, Adh[uf3] , pr, cn/CyO and Df(2L)rl O, cn//n(2LR)O, I, dp [/v/] CyO, P[acUn-lacZ] . All subsequent antibody staining was carried out on mutant embryos that had been previously stained with X-Gal.
PCR was carried out (Saiki et al., 1988) by using gliotactin-specific oligonucleotides and DNA isolated from mutant and control lines. DNA was isolated from heterozygous mutant adults and homozygous mutant embryos. Although the DNA from adults was a mixture of wild type (balancer) and mutant, the smaller PCR products corresponding to the mutant deletions were easily identifiable. For the viable excision, AE2A4a, DNA was obtained from homozygous adults. The PCR products obtained from the AE2A45, AE2,d4b, and AE2A4a excision lines were sequenced.
Antibody and I~-Galactosidase Staining
Immunohistochemistry and X-Gal staining were carried out as described previously (Patel et al., 1987; . The PNS was analyzed by staining with the MAbs 1 D4 (anti-fasciclin II) (G. Helt and C. S. G., unpublished data) and 22C10 (Fujita et al., 1982) . The CNS was assayed with MAb BP102 (A. Bieber, N. Patel, and C. S. G., unpublished data) and MAb 1D4. Muscles were stained with antimyosin MAb (gift of D. P. Kiehart); trachea was stained with anticrumbs MAb (-repass and Knust, 1993) ; and gila were stained using MAb 1F6 (anti-gliotactin) and anti-RK2 (Campbell et al., 1994) . ~-Galactosidase in embryos was detected by using X-Gal staining as described previously but minus the Triton X-100. The stained embryos were cleared in glycerol (in phosphate-buffered saline), dissected, and photographed.
Electrophysiology
Embryos were collected and staged from timed egg lays. Mutants were placed over marked balancers or out-crossed to Oregon R (both yield the same results). Staged embryos were dissected as reported earlier (Broadie and Bate, 1993) and physiological recordings performed on a single identified neuromuscular junction on muscle 6 (a ventral longitudinal muscle) or a set of junctions on muscle 4 (a dorsal longitudinal muscle) (Bate, 1990) in abdominal segments A2-A3. Whole-cell current recordings from embryonic and larval muscles were made with patch pipettes with resistances of 3-5 megohms by using standard patch-clamp techniques as reported earlier (Broadie and Bate, 1993) . The muscle was voltage-clamped at -60 inV. Signals were amplified by using an Axonpatch-1D (Axon Instruments) patch-clamp amplifier and filtered with an 8-pole Bessel filter at 2 kHz. Data were analyzed with PCLAMP 5.51 software (Axon Instruments). For stimulation experiments, the motor nerve was stimulated with a suction electrode near the point where it exits the CNS (Broadie and Bate, 1993) . Recordings were performed in fly saline. The standard bath consisted of the following (in millimoles per liter): 140 NaCI, 2 KCI, 4 MgCI2, 1.8 CaCI2, 4 NaHCO3, 5 N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), 5 trehalose, 36 sucrose. The K ÷ concentration of this standard bath was modified as indicated. The intracellular solution consisted of the following (in millimoles per liter): 120 KCI, 20 KOH, 4 MgCI2, 5 TES, 5 EGTA, 0.25 CaCI2, 4 ATP, 0.4 GTP, 5 trehalose, 36 sucrose. The pH of all solutions was buffered at 7.15.
Identifying Individual gliotactin Mutant Embryos for EM
To identify gliotactin mutant embryos collected from an 1(2)AE2A4b/ CyO# stock (13 = J~-actin), eggs were screened with the fluorescent LS-galactosidase substrate fluorescein digalactoside (FDG; Molecular Probes, Incorporated) as follows. Embryos for conventional EM were dechorionated and fixed for 10 rain in heptane previously equilibrated with an equal volu me of 50% glutaraldehyde and 10% acrolein in 100 mM sodium cacodylate buffer (pH 7.4). These embryos were then rinsed with heptane, transferred to sodium cacodylate buffer, and manually devitellinized. Embryos for ruthenium red staining were manually devitellinized and opened. The fixation was gentler: 1-2 rain in a solution of lO/o glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.4). After fixation, the embryos were rinsed with sodium cacodylate buffer. The fixed embryos were incubated for 15 min on ice with 1 mM FDG in 100 mM sodium cacodylate buffer (pH 7.4), rinsed with sodium cacodylate buffer, and examined at room temperature for fluorescein isothiocyanate fluorescence. Nonfluorescent embryos (AE2A4b homozygous, and Canton S or AE2A4a controls) were processed as described below.
Conventional EM
Embryos collected and screened as described above were fixed for an additional 2 hr with 2% glutareldehyde in 100 mM sodium cacodylate buffer (pH 7.4), rinsed in buffer, and posffixed with 1O/o OsO4 in 100 mM sodium cacodylate buffer. Posffixed embryos were rinsed with buffer followed by distilled water and then stained en bloc with 1% aqueous uranyl acetate. After staining, the embryos were rinsed with water, dehydrated in an ethanol series followed by propylene oxide, and embedded in Eponate 12 resin. Serial 100 nm sections were cut, picked up on Formvar film-coated slot grids, and stained with uranyl acetate followed by Sato's lead (Sato, 1968) . Sections were photographed with a JEOL 1200EX/II electron microscope.
Ruthenium Red Staining
Embryos collected and screened as described above were fixed for an additional 1-2 hr with 2% glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.4) to which 1.5-3.0 mg/ml of ruthenium red (Aldrich Chemical Company) was added. Following fixation, the embryos were rinsed in buffer containing ruthenium red and postfixed with lO/o OsO4 in sodium cacodylate buffer containing ruthenium red. Postfixed embryos were rinsed in buffer without ruthenium red and were further processed for EM as described above, except they were not en bloc stained with uranyl acetate following postfixation.
